HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...

President Donald Trump is remaking the traditional boundaries of Washington, asserting unprecedented executive power and ...

Don Dempsey reportedly in frame to serve as Office of Management and Budget’s leading health offical, a role that would hand him sweeping powers to rein in Kennedy’s ambitions ...

Robert Lighthizer, the former U.S. Trade Representative, lost his bid to rejoin the White House, but he still believes the ...

Sen. John Fetterman is scaring liberals by cozying up to President-elect Trump. He’s acting like the wildcard successor to ...

Editorial page editor Jim Dao sits down with Globe Opinion columnist Joan Vennochi and Globe political reporter James Pindell ...

Restored to power, President Trump claimed that God put him there and asserted the right to single-handedly redraw the world ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...